Omnicell, Inc. (FRA:OC9)

Market Cap	1.29B -7.0%
Revenue (ttm)	1.01B +6.5%
Net Income	1.75M -83.6%
EPS	0.03 -85.2%
Shares Out	n/a
PE Ratio	739.04
Forward PE	18.82
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	5
Open	30.60
Previous Close	30.40
Day's Range	30.60 - 30.60
52-Week Range	21.60 - 43.80
Beta	n/a
RSI	43.57
Earnings Date	May 1, 2026

About Omnicell

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-hous...

• Industry: Special Industry Machinery, not elsewhere classified
• Founded: 1992
• Employees: 3,580
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OC9

Financial Performance

In 2025, Omnicell's revenue was $1.18 billion, an increase of 6.53% compared to the previous year's $1.11 billion. Earnings were $2.05 million, a decrease of -83.62%.

Financial numbers in USD